FibroBiologics Inc
FBLG
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.92M
Close$
$1.11
30.6% upside
Current Fair Value
30.6% upsideUndervalued by 30.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.92 Million |
|---|---|
| Enterprise Value | $2.67 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-8.4 |
| Beta | 1.17 |
| Outstanding Shares | 2,233,026 |
Return
| Return on Equity | -718.46% |
|---|---|
| Return on Assets | -314.58% |
| Return on Invested Capital | -447.21% |
Valuation & Multiples
| P/E Ratio | -0.11 |
|---|---|
| PEG | -16.29 |
| Price to Sales | - |
| Price to Book Ratio | 0.85 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -0.15 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.84 |
| Debt to Equity | 0.86 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 19, 2026
EPS Estimate
$-0.07
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
July 30, 2026
EPS Estimate
$-0.93
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 9.88%▼ 0.00% |
|---|---|
| Total Invested | $291,326▼ 70.68% |
| Investors Holding | 17▼ 27.00% |
ESG Score
No data